Singapore firm saves 150bp by pledging RMB for USD funding – interview
The Singapore-listed medical device manufacturer, Biosensors, plans to place higher yielding renminbi as collateral in exchange for cheaper US dollar financing to fund its operations, says CFO Ronnie Ede.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ 4 capital markets databases
- ✔ Daily newsletters across markets and asset classes
- ✔ 2 weekly podcasts